Skip to main content
Guidance

Drugs and pharmaceutical electronic market information tool (eMIT)

The eMIT provides information about prices and usage for generic drugs and pharmaceutical products.

Updates to this page

From:
Department of Health and Social Care
Published:
16 March 2011
Last updated:
10 August 2026
Show all updates

  1. Spreadsheet updated with data from the 12-month period to the end of June 2026.

  2. Spreadsheet updated to correct an error in pricing.

  3. Spreadsheet updated with data from the 12-month period to the end of June 2025.

  4. Spreadsheet updated with data from the 12-month period to the end of December 2024.

  5. Spreadsheet updated with data from the 12-month period to the end of June 2024.

  6. Spreadsheet updated with data from the 12-month period to the end of December 2023.

  7. Document updated with data from the 12-month period to the end of June 2023.

  8. Document updated with data from the 12-month period to the end of December 2022.

  9. Document updated with data from the 12-month period to the end of June 2022.

  10. Document updated with data from the 12-month period to the end of June 2021.

  11. Replaced document and changed date.

  12. Document updated with data from the 12-month period to the end of December 2019.

  13. Document updated with data from the 12-month period to the end of June 2019.

  14. Document updated with data from the 12-month period to the end of December 2018.

  15. Document updated with data from the 12-month period to the end of June 2018.

  16. Document updated with data from the 12-month period to the end of June 2017.

  17. Document updated with the latest market information.

  18. The data within the eMIT represents the 12 month period to the end of December 2015.

  19. The data within the eMIT represents the 12 month period to the end of June 2015.

  20. First published.

Documents

eMIT national database

ODS, 170 KB

This file is in an OpenDocument format

Details

This tool gives background information on the pharmaceuticals that hospitals might buy.

The data provided includes:

  • an estimate of NHS hospital-sector annual usage from English trusts for the product selected
  • the average price paid for that product over the last 4 months of the period (exclusive of VAT)
  • a measure of how much that average changed

The data in the eMIT represents the 12-month period to the end of June 2026.

The data has been manipulated to protect the confidentiality of framework agreement prices where necessary.

Sign up for emails or print this page